Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind Sequential Parallel Study of Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

NCT03764683 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03764683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03764683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind Sequential Parallel Study of Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Withdrawn
Start date
February 26, 2019
Completion date
January 6, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, insomnia